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Abstract: The Mediterranean diet (MD) is recognised as one of the healthiest diets worldwide and 
is associated with the prevention of cardiovascular and metabolic diseases, among others. Dietary 
habits are considered one of the strongest modulators of the gut microbiota, which seems to play a 
significant role in the health and disease of the host. The purpose of the present study was to 
evaluate interactive associations between gut microbiota composition and habitual dietary intake 
in 360 Spanish adults of the Obekit cohort (normal weight, overweight and obese subjects). Dietary 
intake and adherence to the MD tests together with faecal samples were collected from each 
subject. Faecal 16S rRNA sequencing was performed and checked against the dietary habits. 
MetagenomeSeq was the statistical tool applied to analyse at the species taxonomic level. Results 
from this study confirm that a strong adherence to the MD increases the population of some 
beneficial bacteria, improving microbiota status towards a healthier pattern. Bifidobacterium 
animalis is the species with the strongest association with the MD. One of the highlights is the 
positive association between several SCFA-producing bacteria and high adherence to the MD. In 
conclusion, this study shows that MD, fibre, legumes, vegetables, fruit and nuts intakes are 
associated with an increase in butyrate-producing taxa such as Roseburia faecis, Ruminococcus bromii 
and Oscillospira (Flavonifractor) plautii. 
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1. Introduction 
The gut microbiota status has a direct impact on the health and disease of the host [1]. Dietary 
habits are considered one of the strongest modulators of the gut microbiota. Serious conditions can 
show up due to sedentarism and bad dietary habits: hypertrophied adipocytes release inflammatory 
molecules (i.e., interleukins and tumour necrosis factor) which, over enough time, can favour the 
development of several inflammation-related disorders such as metabolic syndrome, cardiovascular 
disease, colorectal cancer, neurodegenerative diseases [2,3] and autoimmune disorders like Crohn’s 
disease, ulcerative colitis and allergies [4]. In this context, the Mediterranean diet (MD) is recognised 
as one of the healthiest diets worldwide. Therefore, we would expect a modulation of the gut 
microbiota as one of the positive health effects of the MD [5]. The main objective of the present work 
relays on the bacteria that are more closely associated with a high adherence to the MD. 
2. Material and Methods 
2.1. Subjects 
This cross-sectional study enrolled 360 Spanish adults (251 females and 109 males) ranging 45.0 
± 10.5 years old. Major exclusion criteria included a history of diabetes mellitus, cardiovascular 
disease and hypertension, pregnant or lactating women and current use of lipid-lowering drugs. 
2.2. Anthropometric and Biochemical Measurements 
The volunteers were classified as normal weight when BMI: 18.5–24.9 kg/m2 (n = 64), 
overweight when BMI: 25.0–29.9 kg/m2 (n = 115), and obesity when BMI > 30.0 kg/m2 (n = 181). Blood 
biochemistry (glucose, total cholesterol (TC), high-density lipoprotein cholesterol (HDL) and 
triglycerides) was analysed. Insulin resistance index (HOMA-IR) was calculated. 
2.3. Dietary Estimation 
Habitual dietary intake at baseline was collected with a validated food frequency questionnaire 
[6]. A 14-item questionnaire, the PREDIMED validated test, was also used in this study of adherence 
of participants to the MD [7]. 
2.4. Faecal Sample Collection and DNA Extraction 
2.4.1. Metagenomic Data: Library Preparation 
Metagenomics studies were performed by analysing the variable regions V3–V4 of the 
prokaryotic 16S ribosomal RNA gene (16S rRNA), which gives 460 bp amplicons in a two-round 
PCR protocol. Finally, paired-end sequencing was performed in a MiSeq platform (Illumina, Inc., 
San Diego, CA, USA). 
2.4.2. Metagenomics Data: Analysis and Processing 
16S rRNA sequences obtained were filtered following quality criteria of the operational 
taxonomic units (OTU) processing pipeline LotuS (release 1.58) [8]. Taxonomy was assigned using 
HITdb, achieving up to species-level sensitivity. BLAST was used when HITdb failed to reach a 
homology higher than 97% [9,10]. Global normalisation was performed using the library size as a 
correcting factor and log2 data transformation [11]. 
  
Proceedings 2020, 61, 10 3 of 8 
 
2.5. Statistical Analysis 
The Microbiome Analyst tool [12] was used for statistical differences in microbiota profiles 
between groups (tertiles) through the zero-inflated Gaussian approach of metagenomeSeq and using 
cumulative sum scaling (CSS) normalisation. 
3. Results 
Microbiota Composition: MD Adherence 
MD tertiles 1 and 3 were compared through metagenomeSeq analysis. Significant differences 
appeared when comparing both tertiles (FDR < 0.05). Species shown in Table 1 are strongly 
influenced by the MD score. Subjects with a higher adherence to the MD are represented in the third 
tertile, while those who are far from the MD model are in the first tertile. This work focuses on the 
high-adherence species and their distribution, with box plots (Figure 1). All box plots represent 
those species with significant differences between high- and low-adherence tertiles. 
Table 1. Bacterial species with a significant relation with adherence to the MD (FDR < 0.05) by 
metagenomeSeq test. 
High Adherence (3rd tertile) Low Adherence (1st tertile) 
Species FDR Species FDR 
Bifidobacterium animalis 1.21 × 10−7 
OTU100|NN=Eubacterium saphenum 
GU427005|D=91 
4.44 × 10−5 
















OTU1065|NN=Oscillospira (Flavonifractor) plautii 
Y18187|D=86.6 
3.42 × 10−5 Christensenella minuta 0.0020 









0.0120 Alistipes timonensis 0.0155 
Erysipelatoclostridium ramosum 0.0176 Prevotella corporis 0.0192 
OTU521|NN=Papillibacter cinnamivorans 
AF167711|D=89 
0.0463   
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OTU946|NN=Paraprevotella clara OTU1517|NN=Catabacter hongkongensis 
Figure 1. Bacterial species that were significantly more abundant in the group with high adherence to the Mediterranean diet (MD) (FDR < 0.05) by the metagenomeSeq 
test. Red boxes represent subjects with a higher adherence to the MD and blue boxes represent low adherence. 
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4. Discussion 
The gut microbiota co-develops with the host, and its bacterial proportions are modified by the 
action of the diet and other extrinsic stressors [13]. 
MD High Adherence Species 
High MD adherence has many beneficial outputs to human health. It is a great resource to 
manage obesity-related comorbidities, such as cardiovascular diseases, type 2 diabetes and 
pro-inflammatory conditions [14–16]. Table 1 shows those species that are more associated with 
adherence to the MD. 
Bifidobacterium animalis belongs to the phylum Bacteroides, associated with obesity-related 
alterations in bacterial gut microbiota, and the genus Bifidobacterium might have a critical role in 
weight regulation [17]. B. animalis subsp. lactis GCL2508 is a probiotic strain with an antimetabolic 
syndrome effect [18], capable of proliferating and producing SCFA in the gut. These compounds 
have a regulatory effect on inflammatory conditions [19]. Bacteroides cellulosilyticus degrades 
cellulose [20], with an unprecedented number of carbohydrate-active enzymes providing a versatile 
carbohydrate utilisation [21]. Paraprevotella clara, a common member of the human intestinal 
microbiota [22], is closely related to carbohydrate-active enzymes known to degrade insoluble fibre 
[23]. Indeed, P. clara is known to produce acetic acid [22]. Oscillibacter valericigenes produces valeric 
acid, an SCFA [24]. Valeric acid has been reported to have an inhibitory effect on histone deacetylase 
(HDAC) isoforms implicated in a variety of pathologies such as cancer, colitis and cardiovascular 
and neurodegenerative diseases [25]. High levels of Oscillospira (Flavonifractor) plautii have been 
strongly correlated with a high production of SCFA, especially propionate and butyrate [26]. This 
species correlates with a lean host phenotype [27]. Furthermore, the Oscillospira genus has been 
correlated with the production of secondary bile acids known to prevent Clostridium 
difficile-associated infectious disease in humans [28]. Roseburia faecis is a butyrate producer whose 
abundance has been directly related to weight loss and a reduced glucose intolerance in mice [29]. 
Catabacter hongkongensis is common in the human intestinal microbiota [30]. Ruminococcus bromii has 
been related to diets rich in fibres and resistant starch and greatly contributes to butyrate production 
in the colon [31]. 
It is important to highlight some beneficial effects of butyric acid as it has been reported to 
improve the intestinal barrier integrity [32], regulate cell apoptosis [33], stimulate production of 
anaerobic hormones [34] and, by inducing differentiation of colonic regulatory T cells, suppress 
inflammatory and allergic responses [35]. On the other hand, many conditions have been associated 
with low levels of butyrate, such as colon cancer or obesity [31]; therefore, increased butyrate 
production in the colon may be beneficial to human health. 
Erysipelatoclostridium ramosum is a member of the Erysipelotrichaceae family known to interfere 
in various ways with the enterohepatic circulation and excretion of bilirubin, transforming it into 
urobilin [36]. Papillibacter cinnamivorans is not well known but has been found in lower amounts in 
centenaries than in any other age [37]. 
5. Conclusions 
Our results indicate that the well-known beneficial factors of the MD may be triggered by 
changes in intestinal microbiota due to diet habits. A high adherence to the MD seems to increase the 
abundance of some species associated with health: Bifidobacterium animalis, Oscillibacter valericigenes, 
Oscillospira (Flavonifractor) plautii, Roseburia faecis, Ruminococcus bromii, Butyricicoccus pullicaecorum 
and Papillibacter cinnamivorans. This study strongly suggests that the MD increases butyrate 
production from R. faecis, R. Bromi and Oscillospira (Flavonifractor) plautii. Erysipelatoclostridium 
ramosum is the only bacteria from this study that does not show a clear beneficial effect on health, 
although this identification should be taken with caution. A deeper taxonomy is required to put 
some light into it. 
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